Evogliptin

From Infogalactic: the planetary knowledge core
Jump to: navigation, search

Evogliptin (trade name Suganon, previously identified as DA-1229, Dong-A ST) is an antidiabetic drug in the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.[1] It was developed by the South Korean pharmaceutical company Dong-A.

References

<templatestyles src="Reflist/styles.css" />

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
  1. ↑ Lua error in package.lua at line 80: module 'strict' not found.
Retrieved from "https://infogalactic.com/w/index.php?title=Evogliptin&oldid=709440871"